Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 4,056 shares at $25.09 ($102K) on 2018-07-03, disclosed to the SEC on 2018-07-06.
Open-market sale of $102k CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.09 | 2,028 | $51K | 50.0% |
| 2 | $25.09 | 2,028 | $51K | 50.0% |
| Total | $25.09 avg | 4,056 | $102K | 100% |
| Filing → |
| CTMX | SELL | 2025-11-10 | $924K | — | Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |